← Eichor
Condition: Schizophrenia And Other Psychotic Disorders Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Schizophrenia And Other Psychotic Disorders

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Deep Brain Stimulation for Psychosis
NA · 1 location(s) · Bradley Lega · NCT06257056
Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Control Trial.
NA · 1 location(s) · All India Institute of Medical Sciences, Bhubaneswar · NCT06505668
Synergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizop
NA · 1 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT07058389
Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
NA · 3 location(s) · University of California, San Diego · NCT07098169
Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Anal
NA · 1 location(s) · Shanghai Mental Health Center · NCT06904079
App and Body Fat Scale in the Management of Overweight Patients
NA · 1 location(s) · Capital Medical University · NCT05866107
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
Phase 4 · 1 location(s) · Mayo Clinic · NCT07213466
Sex Differences in NMDA-enhancing Treatment of Schizophrenia
Phase 2 · 1 location(s) · China Medical University Hospital · NCT07122895
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
Phase 1 · 5 location(s) · BioXcel Therapeutics Inc · NCT05025605
Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis
NA · 1 location(s) · The Royal Ottawa Mental Health Centre · NCT05973110
RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders
NA · 1 location(s) · Ciusss de L'Est de l'Île de Montréal · NCT05704582
Efficacy of Hi-tACS for Schizophrenia Negative Symptoms
NA · 1 location(s) · Shanghai Mental Health Center · NCT06888726
Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis
NA · 1 location(s) · Fundació Sant Joan de Déu · NCT07091344
Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia
NA · 1 location(s) · Mclean Hospital · NCT05343598
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06961916
Combining mHealth and Nurse-delivered Care to Improve the Outcomes of People With Serious Mental Illness in West Africa
NA · 1 location(s) · University of Washington · NCT05703711
Mechanisms of Response to Therapeutic Intervention in Clinical High Risk (CHR) for Psychosis
NA · 1 location(s) · Beth Israel Deaconess Medical Center · NCT06542640
Personalized iTBS in Real-World Clinical Settings for Schizophrenia
NA · 2 location(s) · Anhui Medical University · NCT07176468
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
NA · 1 location(s) · University of California, Los Angeles · NCT05890183
Study of Intra- and Interpersonal Multimodal Synchronizations in a Social Interaction in Individuals with a Diagnosis of
NA · 1 location(s) · University Hospital, Montpellier · NCT06484387
Synbiotic Compound to Reduce Symptoms of Schizophrenia
Phase 2 · 1 location(s) · Sheppard Pratt Health System · NCT04226898
Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study.
Phase N/A · 1 location(s) · Health Service Executive, Ireland · NCT05074732
Karolinska Schizophrenia Project
Phase N/A · 1 location(s) · Karolinska Institutet · NCT06872463
A Study of Brenipatide in Adult Participants With Schizophrenia
Phase 2 · 102 location(s) · Eli Lilly and Company · NCT07410507
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Phase 3 · 15 location(s) · Neurocrine Biosciences · NCT07105098
Efficiency Assessment of BREFORM. A Multicentric Stepped-wedge Randomized Control Trial.
NA · 1 location(s) · Hôpital le Vinatier · NCT05036590
Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness
NA · 2 location(s) · Centre hospitalier de Ville-Evrard, France · NCT07316803
SloMo2: Implementation, Effectiveness, and Cost-effectiveness Study
NA · 1 location(s) · King's College London · NCT06568081
Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07509125
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Phase N/A · 6 location(s) · Beth Israel Deaconess Medical Center · NCT06740383
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.